Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ALK, ROS1 and EGFR status of lung cancers in the Aegean Region of Turkey.

Indian journal of pathology & microbiology - 1 Jan 2000

Diniz Gulden, Komurcuoglu Berna, Ozyilmaz Berk, Ozguzer Alp, Yucel Nur, Kirbiyik Ozgur

Abstract excerpt

Background/Aims: As targeted therapies are promising in the treatment of lung cancer (LC), it is important to identify the genetic variations in tumors. The present research aimed to determine the regional prevalence of alterations in ALK, ROS1, and EGFR genes. Materials and. Methods: ALK rearrangement in 1152, ROS1 rearrangement in 390, and EGFR mutations in 1054 cases with LC were evaluated. Results: Alteration...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Rearrangement

Share to Genes, erbB-1

Share to Lung Neoplasms

Share to Protein-Tyrosine Kinases

Share to Proto-Oncogene Proteins

Share to Turkey

Source

Identifiers

PMID: 35435363
DOI: 10.4103/IJPM.IJPM_1129_20

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ALK, ROS1 and EGFR status of lung cancers in the Aegean Region of Turkey.PMID 35435363Read ↗

Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusionsSemantic proximity Read ↗

Driver gene alterations in lung adenocarcinoma: Demographic features of 2544 Chinese cases.Semantic proximity Read ↗

Regional distribution of genetic mutation in lung cancer in Turkey (REDIGMA).Semantic proximity Read ↗

High prevalence of ROS1 gene rearrangement detected by FISH in EGFR and ALK negative lung adenocarcinoma.Semantic proximity Read ↗

Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions.Semantic proximity Read ↗

Investigation of EGFR and ALK mutation frequency and treatment results in advanced non-small cell lung cancer.Semantic proximity Read ↗

EGFR Mutation in Non-squamous Non-small-cell Lung Carcinoma (NS-NSCLC) in the Arab World: A systematic Review.Semantic proximity Read ↗

EGFR mutations and ROS1 and ALK rearrangements in a large series of non-small cell lung cancer in South India.Semantic proximity Read ↗

Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations.Semantic proximity Read ↗

Progress of non-small-cell lung cancer with ROS1 rearrangementSemantic proximity Read ↗

The prevalence and clinical significance of EGFR mutations in non-small cell lung cancer patients in Egypt: a screening study.Semantic proximity Read ↗

EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.